Drugs which alter the levels of, or block the effects of hormones in the treatment of hormone-sensitive cancers, including:• Ovarian suppression, tamoxifen, and aromatase inhibitors in breast cancer treatment.• Androgen deprivation therapy in prostate cancer treatment. Here, CYP19A1 is linked to prostate carcinoma.